Country: Australia
Language: English
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CEPHALEXIN AS CEPHALEXIN MONOHYDRATE
JUROX PTY LIMITED
cephalexin as monohydrate(600mg/Tb)
ORAL TABLET
CEPHALEXIN AS CEPHALEXIN MONOHYDRATE ANTIBIOTIC Active 600.0 mg/Tb
10x10 Tab; 10x6 Tab; 300 Tab
VM - Veterinary Medicine
DOG | BITCH | CASTRATE | PUPPY
ANTIBIOTIC & RELATED
INFECTIONS OF SOFT CUTANEOUS TISSUE | INFECTIONS OF THE DIGESTIVE TRACT | INFECTIONS OF THE RESPIRATORY TRACT | INFECTIONS OF THE URINARY TRACTS | OSTEOMYELITIS | ACUTE RESPIRATORY INFECTIONS | BRONCHISEPTICA | BRONCHITIS | ESCHERICHIA COLI | GROUP D STREPTOCOCCUS | KLEBSIELLA SPP. | PHARYNGITIS | PNEUMONIA | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | STAPHYLOCOCCUS SPP. | TONSILLITIS
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, OSTEOMYELITIS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, OSTEOMYELITIS]; For the treatment of infections in dogs caused by cephalexin sensitive organisms, including infections of soft cutaneous tissue, infections of the respiratory, urinary and digestive tracts, and for the prevention and treatment of osteomyelitis.Contraindicated in animals with a history of allergic reactions to cephalosporins or other penicillins. Nausea & vomiting may occasionally occur.
Registered
2023-07-01
DIRECTIONS FOR USE: CONTRAINDICATION: THIS PRODUCT IS CONTRAINDICATED IN ANIMALS WITH A HISTORY OF ALLERGIC REACTIONS TO CEPHALOSPORINS OR OTHER PENICILLINS. Administer orally: Give 15 mg/kg bodyweight twice per day (equivalent to 1 Cephaforte 600 Tablet per 40 kg bodyweight given night and morning). Duration of treatment is at least 3 days, but may be extended at the discretion of the veterinarian. Nausea and vomiting in dogs may occasionally occur, but these effects are unusual and transitory. FIRST AID: If poisoning occurs, contact a doctor or Poisons Information Centre. Phone 131 126. ANTIBIOTIC TABLETS FOR DOGS ACTIVE CONSTITUENT: Each tablet contains 600 mg CEPHALEXIN (as monohydrate) FOR THE TREATMENT OF INFECTIONS IN DOGS CAUSED BY CEPHALEXIN SENSITIVE ORGANISMS, INCLUDING INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE RESPIRATORY, URINARY AND DIGESTIVE TRACTS, AND FOR THE PREVENTION AND TREATMENT OF OSTEOMYELITIS. PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY JUROX Pty. Ltd. 85 Gardiner Road Rutherford NSW 2320 Infoline 1800 023 312 Dispose of empty container by wrapping with paper and placing in garbage. Store below 30°C (Room Temperature) APVMA No. 60441/300 Tab/0309 300 TABLETS CEPHAFORTE 600 407186 APVMA FILE: 60441_46408_300Tab_immediate_MPL_V02.pdf Dimensions: label = 150mm (wide) x 100mm (high) Scale: 100% of A4 Date: 28 July 2009 APPROVED LABEL Info PEST Verified Cephaforte 600mg antibiotic tablets for dogs AUG09 page 1/2 [60][100] tablets blister packs PRIMARY CONTAINER (CARTON) MAIN PANEL PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CEPHAFORTE 600 ANTIBIOTIC TABLETS FOR DOGS Active Constituent: Each tablet contains 600 mg CEPHALEXIN (as monohydrate) FOR THE TREATMENT OF INFECTIONS IN DOGS CAUSED BY CEPHALEXIN SENSITIVE ORGANISMS, INCLUDING INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE RESPIRATORY, URINARY AND DIGESTIVE TRACTS, AND FOR THE PREVENTION AND TREATMENT OF OSTEOMYELITIS. [60] [100] TABLETS [ Read the complete document
CEPHAFORTE TABLETS Page 1 of 4 ISSUED: 13 JUNE 2012 MATERIAL SAFETY DATA SHEET SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY PRODUCT NAME: CEPHAFORTE TABLETS PRODUCT CODE: 503190 (300 mg tabs), 503195 (600 mg tabs) RECOMMENDED USE: Antibiotic tablets for dogs and cats COMPANY IDENTIFICATION: Jurox Pty Limited ADDRESS: 85 Gardiner Street Rutherford NSW 2320 Australia CUSTOMER CENTRE: 1800 023 312 NATIONAL POISONS INFORMATION CENTRE: 131126 (Australia-wide) EMERGENCY TELEPHONE NUMBER: 1800 023 312 (Monday – Friday, 9.00a.m. – 5.00p.m.) SECTION 2: HAZARDS IDENTIFICATION HAZARD CLASSIFICATIONS: NOT CONSIDERED A HAZARDOUS SUBSTANCE ACCORDING TO THE CRITERIA OF NOHSC AUSTRALIA. NOT CONSIDERED A DANGEROUS GOOD ACCORDING TO THE CRITERIA OF THE AUSTRALIAN DANGEROUS GOODS (ADG) CODE. POISONS SCHEDULE: S4 RISK PHRASES: Cephalosporins may cause severe allergic reactions in some sensitive individuals Ingestion may produce health damage* Cumulative effects may result following exposure* (* limited evidence) SAFETY PHRASES: Avoid contact with skin SECTION 3: COMPOSITION / INFORMATION ON INGREDIENTS INGREDIENT CAS NO. CONTENT Cephalexin monohydrate 23325-78-2 approx. 40% Other ingredients determined not to be hazardous to 100% CEPHAFORTE TABLETS Page 2 of 4 SECTION 4: FIRST AID MEASURES FIRST AID MEASURES: If swallowed do NOT induce vomiting. If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain open airway and prevent aspiration. Give water to rinse mouth, then provide liquid slowly. Contact a doctor or Poisons Information Centre, phone 131126. If medical advice is needed, have this MSDS or product container or label at hand. INHALATION: Product may be irritating, but significant inhalation exposure is considered to be unlikely. If dust is inhaled, move patient to fresh air. If irritation persists, seek medical attention. INGESTION: If swallowed DO NOT induce vomiting. For advice, contact a doctor or Poisons Information Centre, phone 131126. Seek medical ass Read the complete document
WWW.JUROX.COM.AU Customer Service 1800 023 312 ® Registered Trademark of Jurox Pty Ltd TECHNICAL NOTES ACTIVE CONSTITUENTS Cephalexin 300 mg/tablet, 600 mg/tablet. ACTIONS Cephalexin is a broad spectrum cephalosporin antibiotic which is chemically related to penicillin. Based on its broad spectrum of activity, cephalexin makes an ideal choice for trauma cases where diffusion into bone and joints may be important. It provides a good treatment and prevention for osteomyelitis and supports the needs of surgical prophylaxis. In cases of persistent infection (pyodermas and abscesses) cephalexin is ideal for long-term therapy. MICROBIOLOGY: As cephalexin is resistant to the action of β-lactamases, Cephaforte is active against strains of _Staphylococcus aureus_ that are insensitive to penicillin (or related antibiotics such as ampicillin or amoxycillin). Cephalexin has bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria, including _Staphylococcus_ spp., _Streptococcus_ spp., _Corynebacterium_ spp., _Pasteurella multocida, Escherichia coli,_ _Proteus_ spp., _Micrococcus _spp. and _Moraxella_ spp., causing death of bacterial cells through a diversity of biological and biochemical effects on the cell wall. PHARMACOKINETICS: Cephalexin is acid stable and active when administered orally. Cephalexin has an excellent absorption profile, with distribution through most body fluids and tissues including kidneys, lungs, joints, bone, soft tissues and biliary tract. Cephalexin is excreted unmetabolised in the urine, and so provides high and sustained antibiotic levels in cases of urinary tract infections (UTIs), and such levels are minimally affected by the usual variations in urinary pH associated with UTIs. Removal of the active agent is primarily through glomerular filtration through the kidneys as well as some tubular secretion. The elimination half-life of cephalexin is about one to two hours in dogs and cats. INDICATIONS Treatment of infections in dogs and cats caused by cephalexin-sensiti Read the complete document